Celgene Corp. buy geldnutzer
Start price
24.12.15
/
50%
€109.54
Target price
11.01.16
€133.95
Performance (%)
-15.45%
End price
11.01.16
€92.62
Summary
This prediction ended on 11.01.16 with a price of €92.62. The prediction for Celgene Corp. disappointed with a performance of -15.45%. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
Comments by geldnutzer for this prediction
In the thread Celgene Corp. diskutieren
Auf zu Neuen Kursen
Diese Aktie gehört im Biotech-Sektor zu den Basis-Anlagen.
Hier wird es jetzt weiter nach oben gehen, 2016 kann kommen.
(Vom Mitglied beendet)